ANDREW MILANO: Open Payments
NPI 1144418047 · ABINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 20 payments from 9 companies in 2025. Trend: 2023 $307 · 2024 $379 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $131 |
| ABBVIE INC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| PFIZER INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Amgen Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Kerendia, UBRELVY, PREVNAR 20, VRAYLAR, AIRSUPRA, TRELEGY ELLIPTA, Ozempic, EVENITY.
Industry payments across PA — which companies pay providers there.
